The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Elliott Russell P. since 2018.
The trader's CIK number is 1727807.
At the time of the last reporting, Elliott Russell P. was the VP Drug Development of Foamix Pharmaceuticals Ltd.. (stock ticker symbol FOMX).
Also see all insider trading activities at Foamix Pharmaceuticals Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | FOMX | 0 | $0 | 1,243 | $7,286 | 1,372 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-01 | FOMX | Sale | 142 | 5.81 | 825 |
| 2018-07-02 | FOMX | Sale | 142 | 5.10 | 724 |
| 2018-04-02 | FOMX | Sale | 142 | 5.08 | 721 |
| 2018-03-02 | FOMX | Sale | 817 | 6.14 | 5,016 |
| 2018-01-01 | FOMX | Option Ex | 1,372 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elliott Russell P. (VP Drug Development of Foamix Pharmaceuticals Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.